National Institute of Allergy and Infectious Diseases (NIAID): Encephalitis trials
The registry lists 11 Encephalitis studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 3 have results posted.
Phase 1 5Phase 2 3Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy AdultsCompletedNCT03879603Phase 1Results posted
- Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)TerminatedNCT01031537Phase 2Results posted
- Long Term Treatment of Herpes Simplex Encephalitis (HSE) With ValacyclovirCompletedNCT00031486Phase 3Results posted
- Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of AgeCompletedNCT02186626Phase 1
- Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy AdultsCompletedNCT00118924Phase 1
- Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy AdultsCompletedNCT00094718Phase 1
- IVIG - West Nile Encephalitis: Safety and EfficacyCompletedNCT00068055Phase 1/2
- Structure of the Herpes Simplex Virus ReceptorCompletedNCT00001648
- Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic EncephalitisCompletedNCT00000794Phase 2
- A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDSCompletedNCT00000674Not applicable
- A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii InfectionCompletedNCT00000666Not applicable